Does daily co administration of gonadotropins and letrozole during the ovarian stimulation improve IVF outcome for normal, poor and sub optimal responders?
Gynecologic and Obstetric Investigation · 2025
DOI: 10.1159/000546147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gynecologic and Obstetric Investigation, 2025. Verfasst von Jigal Haas und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Chaim Sheba Medical Center (Tel Hashomer), Ramat Gan, Israel, jigalh@hotmail.com. Hauptthemen laut MEDLINE: Ovulation Induction, Fertilization in Vitro, Gonadotropins, Nitriles.
Abstract (Originalsprache)
Background
Previous studies have described similar or improved IVF outcomes following co-administration of letrozole during ovarian stimulation (OS) in different patients' sub-populations.
Objectives
Address and identify the sub-group of patients that might benefit from letrozole co-treatment throughout the entire OS. Methods,Setting, Participants: We reviewed the medical files of patients attending our IVF unit over a three-year period, for different indications, who underwent two successive IVF cycle attempt, where the 2nd included the co-administration of 5 mg Letrozole from OS day 1 until trigger day.
Results
Two hundred patients met the inclusion criteria and were included in the study. Of whom, 65 were poor responders (oocytes≤ 3) during the first IVF cycle attempt, 85 were sub-optimal responders (4-9 oocytes) and 50 were normal responders (≥ 10 oocytes). The total dose of gonadotropins (4525±1553 vs. 4293±2166, p = NS) and length of stimulation (11.3±2.2 vs. 11.1±2.3, p=NS) were comparable between the two cycle attempts. Numbers of follicles ≥ 13mm (7.2±4.7 vs 6.2±4.3, p < 0.001), retrieved oocytes (8.6±6.1 vs. 6.9±5.5, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Chaim Sheba Medical Center (Tel Hashomer), Ramat Gan, Israel, jigalh@hotmail.com.
- Faculty of Medical and Health Science, Tel Aviv University, Tel Aviv, Israel, jigalh@hotmail.com.
- Department of Obstetrics and Gynecology, Chaim Sheba Medical Center (Tel Hashomer), Ramat Gan, Israel.
- Faculty of Medical and Health Science, Tel Aviv University, Tel Aviv, Israel.
- The Tarnesby-Tarnowski Chair for Family Planning and Fertility Regulation, at the Faculty of Medical and Health Science, Tel-Aviv University, Tel Aviv, Israel.
Zitieren
APA
Haas, J., Orvieto, R., Aizer, A., Maman, E., Noach-Hirsh, M., Marom Haham, L., Lebovitz, O., Shapira, M., & Nahum, R. (2025). Does daily co administration of gonadotropins and letrozole during the ovarian stimulation improve IVF outcome for normal, poor and sub optimal responders?. Gynecologic and Obstetric Investigation. https://doi.org/10.1159/000546147
Vancouver
Haas J, Orvieto R, Aizer A, Maman E, Noach-Hirsh M, Marom Haham L, et al. Does daily co administration of gonadotropins and letrozole during the ovarian stimulation improve IVF outcome for normal, poor and sub optimal responders?. Gynecologic and Obstetric Investigation. 2025. doi:10.1159/000546147
BibTeX
@article{Haas2025,
author = {Haas, Jigal and Orvieto, Raoul and Aizer, Adva and Maman, Ettie and Noach-Hirsh, Merav and Marom Haham, Lilach and Lebovitz, Oshrit and Shapira, Moran and Nahum, Ravit},
title = {Does daily co administration of gonadotropins and letrozole during the ovarian stimulation improve IVF outcome for normal, poor and sub optimal responders?},
journal = {Gynecologic and Obstetric Investigation},
year = {2025},
doi = {10.1159/000546147}
}
EUVIMED